Understanding the Cost of Transfusion Beyond Acquisition (26EL-628)

Transfusion is one of the greatest expenses in the healthcare system. Given the continual increase in healthcare costs, comprehensive cost analyses are key for proper resource utilization and improved patient outcomes. Transfusion costs extend far beyond the acquisition price of blood products, encompassing critical elements like processing, storage, testing, and the procedural aspects of transfusion itself. Current cost analyses, however, often fall short by excluding these activity-based costs and overlooking external and market-based factors, such as component-specific considerations and blood supply limitations. The goal of this eCast is to highlight the factors that should be considered to promote a deeper understanding of the true cost of transfusion to provide blood in the most sustainable and patient-centered manner.

Presented by

• Director/Moderator: Anh Dinh, MD, Assistant Research Physician, National Institutes of Health, Bethesda, MD
  Speakers:

  • Jeremy W. Jacobs, MD, MHS, Assistant Professor, Vanderbilt University Medical Center, Nashville, TN
  • Brian D. Adkins, MD, Assistant Professor, UT Southwestern Medical Center, Dallas, TX

Learning objectives

After participating in this educational activity, participants should be able to:

• Identify the transfusion costs beyond acquisition.
• Recognize the limitations of transfusion cost analyses.
• Discuss the non-financial cost considerations of transfusion.

Registration

Registration includes access to both the live and on-demand version of this eCast. Registration for the live eCast will close 1 hour prior to the eCast start time. If you register after this time, you will receive access to the on-demand eCast when it is available.

For additional information and to register as a single viewer or group, visit the AABB event webpage. Please note: Registration fees are required for AABB events